Succinylcholine pharmacodynamics in peripartum patients

Area of Science:

• Anesthesiology
• Pharmacology
• Biochemistry

Background:

• Serum cholinesterase activity significantly decreases during pregnancy and postpartum.
• This reduction in enzyme activity typically affects the metabolism of certain drugs, like succinylcholine.
• A paradox exists as succinylcholine recovery is not prolonged in term-pregnant patients despite lower cholinesterase levels.

Purpose of the Study:

• To investigate the relationship between serum cholinesterase activity and succinylcholine recovery time.
• To compare these parameters in nonpregnant (oral contraceptive users and non-users), term-pregnant, and postpartum patients.
• To elucidate the reasons behind the normal succinylcholine recovery in term-pregnant individuals.

Main Methods:

• Comparison of serum cholinesterase activity across different patient groups.
• Administration of succinylcholine (1 mg/kg) and measurement of recovery time (25% twitch-height).
• Statistical analysis to determine significant differences between groups.

Main Results:

• Serum cholinesterase activity was significantly lower in term-pregnant and postpartum patients compared to nonpregnant controls.
• Cholinesterase activity was also lower in postpartum patients than in nonpregnant patients using oral contraceptives.
• Succinylcholine recovery time was similar in term-pregnant and nonpregnant patients (with or without oral contraceptives) but significantly prolonged in postpartum patients.

Conclusions:

• The normal duration of succinylcholine action in term-pregnant patients, despite decreased cholinesterase activity, may be attributed to an increased volume of distribution.
• Postpartum patients exhibit prolonged succinylcholine recovery, correlating with their depressed cholinesterase levels.
• These findings highlight distinct pharmacokinetic changes during pregnancy and the postpartum period affecting neuromuscular blockade reversal.